Leucocyte Telomere Shortening in relation to Newly Diagnosed Type 2 Diabetic Patients with Depression

Table 3

Predictors of leukocyte telomere length in type 2 diabetic patients.

	Univariate analysis		Multiple linear regression
	Unstandardized; coefficient (b)	𝑃	Unstandardized; coefficient (b); (95% confidence interval for b)	𝑃
Age	−0.027	0.000	−0.012; (−0.019, −0.005)	0.002
BMI	0.011	0.683
Waist circumference	−0.006	0.390
WHR	0.074	0.920
SBP	−0.005	0.138	−0.006; (−0.010, −0.003)	0.001
DBP	−0.002	0.748
FPG	−0.204	0.000	−0.062; (−0.115, −0.009)	0.023
HbA1c	−0.287	0.000	−0.157; (−0.224, −0.090)	0.000
FIN	−0.003	0.744
HOMA-IR	−0.026	0.135	0.016; (−0.003, 0.035)	0.097
Total cholesterol	−0.014	0.823
Triglyceride	−0.041	0.473
HDL	0.28	0.242
LDL	−0.071	0.326
HADS-D	−0.115	0.000	−0.057; (−0.080, −0.033)	0.000
8-OHdG	−0.599	0.000	−0.238; (−0.369, −0.103)	0.001